885167-73-7 Usage
Uses
Used in Pharmaceutical Industry:
3-Chloropyridine-2-acetic acid is used as a key building block for the synthesis of various pharmaceuticals. Its unique structure allows for the development of new drugs with potential therapeutic applications, such as antimicrobial and anti-inflammatory agents.
Used in Agrochemical Industry:
In the agrochemical industry, 3-Chloropyridine-2-acetic acid serves as a crucial intermediate in the production of various agrochemicals. Its incorporation into these compounds can enhance their effectiveness in controlling pests and diseases, thereby improving crop yields and quality.
Used in Organic Synthesis:
3-Chloropyridine-2-acetic acid is utilized as a versatile building block in organic synthesis. Its reactivity and functional groups enable the formation of a wide range of organic compounds, which can be further used in various applications, such as the development of new materials, dyes, and other specialty chemicals.
Used in Environmentally Friendly Applications:
Due to its low toxicity and minimal environmental impact, 3-Chloropyridine-2-acetic acid is considered suitable for use in environmentally friendly applications. It can be incorporated into green chemistry processes and products, contributing to the development of sustainable and eco-friendly solutions in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 885167-73-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,1,6 and 7 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 885167-73:
(8*8)+(7*8)+(6*5)+(5*1)+(4*6)+(3*7)+(2*7)+(1*3)=217
217 % 10 = 7
So 885167-73-7 is a valid CAS Registry Number.
InChI:InChI=1/C7H6ClNO2/c8-5-2-1-3-9-6(5)4-7(10)11/h1-3H,4H2,(H,10,11)
885167-73-7Relevant academic research and scientific papers
FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS
-
, (2020/01/31)
This application relates to compounds of Formula (I) or pharmaceutically acceptable salts thereof, which modulate the activity of adenosine receptors, such as subtypes A2A and A2B receptors, and are useful in the treatment of diseases related to the activity of adenosine receptors including, for example, cancer, inflammatory diseases, cardiovascular diseases, and neurodegenerative diseases.
UREA DERIVATIVES AND USES THEREOF
-
Paragraph 00562, (2015/01/09)
The present invention provides novel compounds of any one of Formulae (I)-(III), and pharmaceutical compositions thereof. Also provided are particles (e.g., nanoparticles) comprising compounds of Formula (I)-(III) and pharmaceutical compositions thereof that are mucus penetrating. The invention also provides methods and kits for using the inventive compounds, and pharmaceutical compositions thereof, for treating and/or preventing diseases associated with abnormal or pathological angiogenesis and/or aberrant signaling of a growth factor (e.g., vascular endothelial growth factor (VEGF)), such as proliferative diseases (e.g., cancers, benign neoplasms, inflammatory diseases, autoimmune diseases) and ocular diseases (e.g., macular degeneration, glaucoma, diabetic retinopathy, retinoblastoma, edema, uveitis, dry eye, blepharitis, and post-surgical inflammation) in a subject in need thereof.
